Chitosan-based systems for biopharmaceuticals : delivery, targeting, and polymer therapeutics
| Main Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Chichester, West Sussex :
John Wiley & Sons ,
c2012
|
| Subjects: |
Table of Contents:
- 1. Chemical and technological advances in chitins and chitosans useful for the formulation of biopharmaceuticals
- 2. Physical properties of chitosan and derivatives in sol and gel states
- 3. Absorption promotion properties of chitosan and derivatives
- 4. Biocompatibility and biodegradation of chitosan and derivatives
- 5. Biological and pharmacological activity of chitosan and derivatives
- 6. Biological, chemical, and physical compatibility of chitosan and biopharmaceuticals
- 7. Approaches for functional modification or crosslinking of chitosan
- 8. Use of chitosan and derivatives in conventional biopharmaceutical dosage forms formulation
- 9. Manufacture techniques of chitosan-based micro particles and nanoparticles for biopharmaceuticals
- 10. Chitosan and derivatives for biopharmaceutical use : mucoadhesive properties
- 11. Chitosan-based systems for mucosal delivery of biopharmaceuticals
- 12. Chitosan-based delivery systems for mucosal vaccination
- 13. Chitosan-based Nano particulates for oral delivery of biopharmaceuticals
- 14. Chitosan-based systems for ocular delivery of biopharmaceuticals
- 15. Chemical modification of chitosan for delivery of DNA and SIRNA
- 16. Target-specific chitosan-based nanoparticle systems for nucleic acid delivery
- 17. Functional PEGylated chitosan systems for biopharmaceuticals
- 18. Stimuli-sensitive chitosan-based systems for biopharmaceuticals
- 19. Chitosan copolymers for biopharmaceuticals
- 20. Application of chitosan for anti-cancer biopharmaceutical delivery
- 21. Chitosan-based biopharmaceuticals scaffolds in tissue engineering and regenerative medicine
- 22. Wound healing properties of chitosan and its use in wound dressing biopharmaceuticals
- 23. Toxicological properties of chitosan and derivatives for biopharmaceutical applications
- 24. Regulatory status of chitosan and derivatives
- 25. Patentability and intellectual property issues related with chitosan-based biopharmaceutical products
- 26. Quality control and good manufacturing practice (GMP) for chitosan-based biopharmaceutical products
- 27. Preclinical and clinical use of chitosan and derivatives for biopharmaceuticals : from preclinical research to the bedside